Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.56 |
| ▸ | CA1 | P00915 | 1/20 | 0.56 |
| ▸ | CA9 | Q16790 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17456517 | 0.97 | CA2 (0.54) | CA2CA1CA9HTTTSHR | |
| SCHEMBL17456425 | 0.97 | CA2 (0.54) | CA2CA1CA9HTTTSHR | |
| SCHEMBL17456411 | 0.85 | CA1 (0.48) | CA2CA1CA9 | |
| SCHEMBL17469735 | 0.83 | CA2 (0.39) | CA2CA1CA9HTTTSHR | |
| SCHEMBL17469882 | 0.83 | CA2 (0.39) | CA2CA1CA9TSHRTDP1 | |
| SCHEMBL28020107 | 0.83 | CA1 (0.42) | CA2CA1CA9 | |
| SCHEMBL17456442 | 0.81 | CA2 (0.37) | CA2CA1CA9TSHRTDP1 | |
| SCHEMBL17456378 | 0.81 | CA2 (0.37) | CA2CA1CA9HTTTSHR | |
| SCHEMBL775983 | 0.79 | CA1 (0.65) | CA2CA1CA9HTT | |
| SCHEMBL17469885 | 0.79 | CA2 (0.36) | CA2CA1CA9HTTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3305753-B1 | LITHIUM SALT COMPOUND, NONAQUEOUS ELECTROLYTE SOLUTION USING SAME, LITHIUM ION SECONDARY BATTERY AND LITHIUM ION CAPACITOR | UBE INDUSTRIES (JP) | 2020-08-19 | — | — | EP | claimed |
| EP-2183220-B1 | BIODEGRADABLE SOLVENTS FOR THE CHEMICAL INDUSTRY | UNIV DUBLIN CITY (IE) | 2016-11-09 | — | — | EP | claimed |
| US-8541598-B2 | Biodegradable solvents for the chemical industry | DUBLIN CITY UNIVERSITY (IE) | 2013-09-24 | — | — | US | claimed |
| US-20110201824-A1 | BIODEGRADABLE SOLVENTS FOR THE CHEMICAL INDUSTRY | DUBLIN CITY UNIVERSITY (IE) | 2011-08-18 | — | — | US | claimed |
| EP-2183220-A1 | BIODEGRADABLE SOLVENTS FOR THE CHEMICAL INDUSTRY | Dublin City University (IE) | 2010-05-12 | — | — | EP | claimed |
| WO-2009024607-A1 | BIODEGRADABLE SOLVENTS FOR THE CHEMICAL INDUSTRY | DUBLIN CITY UNIVERSITY (IE) | 2009-02-26 | — | — | WO | claimed |
| WO-2024095797-A1 | ELECTROLYTE SOLUTION, ELECTROCHEMICAL DEVICE, SECONDARY BATTERY, AND LITHIUM ION SECONDARY BATTERY | ダイキン工業株式会社 | 2024-05-10 | — | — | WO | disclosed |
| US-20240109858-A1 | Compound, Non-Aqueous Electrolyte Solution Including the Same, and Lithium Secondary Battery | LG CHEM, LTD. (KR) | 2024-04-04 | — | — | US | disclosed |
| US-11855260-B2 | Nonincendive electrolyte for lithium secondary battery, and lithium secondary battery including same | THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY (IAC) (KR) | 2023-12-26 | — | — | US | disclosed |
| EP-4269398-A1 | COMPOUND, NONAQUEOUS ELECTROLYTIC SOLUTION COMPRISING SAME, AND LITHIUM SECONDARY BATTERY | Lg Chem, Ltd. (KR) | 2023-11-01 | — | — | EP | disclosed |
| US-20230327208-A1 | ELECTROLYTES FOR LITHIUM BATTERIES | UCHICAGO ARGONNE, LLC (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230253563-A1 | ELECTROACTIVE MATERIALS FOR SECONDARY BATTERIES | UCHICAGO ARGONNE, LLC (US) | 2023-08-10 | — | — | US | disclosed |
| US-20230246230-A1 | ELECTROLYTES FOR LITHIUM BATTERIES | UCHICAGO ARGONNE, LLC (US) | 2023-08-03 | — | — | US | disclosed |
| EP-2183220-A1 | BIODEGRADABLE SOLVENTS FOR THE CHEMICAL INDUSTRY | Dublin City University (IE) | 2010-05-12 | — | — | EP | disclosed |
| WO-2009024607-A1 | BIODEGRADABLE SOLVENTS FOR THE CHEMICAL INDUSTRY | DUBLIN CITY UNIVERSITY (IE) | 2009-02-26 | — | — | WO | disclosed |
| US-20050010044-A1 | Polysaccharides and methods and intermediates useful for their preparation | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-01-13 | — | — | US | disclosed |
| WO-2005000907-A1 | SULFO-PROTECTED POLYSACCHARIDES AND METHODS AND INTERMEDIATES USEFUL FOR THEIR PREPARATION | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2005-01-06 | — | — | WO | disclosed |
| US-6140508-A | USEFUL IN THE PREPARATION OF FARNESYL-PROTEIN TRANSFERASE INHIBITORS. | MERCK & CO., INC. (US) | 2000-10-31 | — | — | US | disclosed |
| WO-2000001691-A1 | PROCESS FOR MAKING FARNESYL-PROTEIN TRANSFERASE INHIBITORS | MERCK & CO., INC. (US) | 2000-01-13 | — | — | WO | disclosed |
| WO-2000001674-A1 | PROCESS FOR MAKING 1,5-DISUBSTITUTED IMIDAZOLES | MERCK & CO., INC. (US) | 2000-01-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110201824-A1 | BIODEGRADABLE SOLVENTS FOR THE CHEMICAL INDUSTRY | TIMM9, B2M, TIMM44 | CA2 2237/4885CA1 4016/4885CA9 385/4885 |
| US-20240109858-A1 | Compound, Non-Aqueous Electrolyte Solution Including the Same, and Lithium Secondary Battery | KCNN2, KCNN1, HCN2 | CA2 318/4885CA1 281/4885CA9 340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.